StockData

Exicure, Inc. (XCUR) income statement

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.98−0.06 (-5.77%)

Close on Nov 19, 2026Market cap $6.42MP/E –Yield –

Exicure, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2025
-92.5%

Financial strength

Current ratio
0.56
Debt to equity
–
Debt to assets
–
Cash to current liabilities
41.2%

Valuation

P/E ratio
–
Price to sales
–
Price to book
6.57
Dividend yield
–

See a number that looks wrong?